Clinical Trial Update: PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of two Bepotastine formulations in allergic rhinitis and urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Bepotastine besilate (Bepotastine besilate)
• Bepotastine salicylate (bepotastine salicylate)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Allergic Rhinitis, Urticaria | Phase 1 | Status: COMPLETED